Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-17 Sale |
2023-01-18 4:19 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP, Chief Strategy Officer |
27,129 | $113.03 | $3,066,323 | 56,338 (Direct) |
View |
| 2023-01-13 Sale |
2023-01-17 8:32 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Cox Aaron EVP, Chief Financial Officer |
36,148 | $113.17 | $4,090,847 | 277 (Direct) |
View |
| 2023-01-10 Sale |
2023-01-12 4:29 pm |
Horizon Therapeutics Public Ltd Co | HZNP | SHERMAN JEFFREY W EVP and Chief Medical Officer |
6,736 | $113.07 | $761,673 | 236,645 (Indirect Direct) |
View |
| 2023-01-06 Sale |
2023-01-06 5:54 pm |
Horizon Therapeutics Public Ltd Co | HZNP | SHERMAN JEFFREY W EVP and Chief Medical Officer |
5,187 | $113.29 | $587,635 | 288,442 (Indirect Direct) |
View |
| 2022-12-13 Sale |
2022-12-14 5:10 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP, Chief Strategy Officer |
30,169 | $112.6 | $3,397,171 | 34,047 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-13 4:12 pm |
Horizon Therapeutics Public Ltd Co | HZNP | SHERMAN JEFFREY W EVP and Chief Medical Officer |
28,352 | $111.45 | $3,159,692 | 153,535 (Indirect Direct) |
View |
| 2022-08-04 Purchase |
2022-08-08 4:18 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Clayton Sean M. EVP, General Counsel |
745 | $66.67 | $49,669 | 745 (Indirect) |
View |
| 2022-07-29 Sale |
2022-07-29 5:21 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP and Chief Business Officer |
4,850 | $82.57 | $400,483 | 34,047 (Direct) |
View |
| 2022-07-19 Sale |
2022-07-20 6:19 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Thompson Elizabeth H.Z. EVP, Research & Development |
6,007 | $85 | $510,598 | 6,969 (Direct) |
View |
| 2022-07-07 Sale |
2022-07-11 6:03 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Thompson Elizabeth H.Z. EVP, Research & Development |
82 | $85.01 | $6,971 | 12,976 (Direct) |
View |
| 2022-06-10 Sale |
2022-06-13 4:19 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP and Chief Business Officer |
762 | $85.36 | $65,044 | 38,897 (Direct) |
View |
| 2022-06-03 Sale |
2022-06-03 7:04 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
25,000 | $92.34 | $2,308,468 | 1,427,630 (Indirect Direct) |
View |
| 2022-05-31 Sale |
2022-06-02 4:13 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
25,000 | $92.48 | $2,311,980 | 684,511 (Indirect Direct) |
View |
| 2022-05-20 Sale |
2022-05-20 6:15 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
25,000 | $90 | $2,250,000 | 1,477,076 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-13 Gift |
2023-03-14 4:45 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Thompson Elizabeth H.Z. EVP, Research & Development |
2,000 | $0 | 14,575 (Direct) |
View |
| 2023-03-01 Tax Withholding |
2023-03-06 4:52 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Clayton Sean M. EVP, General Counsel |
7,032 | $110.34 | 36,379 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-06 4:52 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Clayton Sean M. EVP, General Counsel |
14,129 | $0 | 36,379 (Direct) |
View |
| 2023-03-02 Exercise |
2023-03-06 4:48 pm |
N/A 2026-12-14 |
Horizon Therapeutics Public Ltd Co | HZNP | DesJardin Michael A. EVP, Technical Operations |
4,372 | $0 | 126,558 (Direct) |
View |
| 2023-03-02 Exercise |
2023-03-06 4:48 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | DesJardin Michael A. EVP, Technical Operations |
743 | $17.19 | 126,558 (Direct) |
View |
| 2023-03-02 Exercise |
2023-03-06 4:48 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | DesJardin Michael A. EVP, Technical Operations |
3,629 | $14.93 | 126,558 (Direct) |
View |
| 2023-01-17 Gift |
2023-01-18 4:21 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | SHERMAN JEFFREY W EVP and Chief Medical Officer |
33,795 | $0 | 236,645 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 5:56 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | McIlvenny Patrick Chief Accounting Officer |
11,498 | $0 | 23,821 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-06 5:56 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | McIlvenny Patrick Chief Accounting Officer |
15,946 | $0 | 23,821 (Direct) |
View |
| 2023-01-05 Tax Withholding |
2023-01-06 5:56 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | McIlvenny Patrick Chief Accounting Officer |
4,147 | $113.24 | 23,821 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 5:54 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | SHERMAN JEFFREY W EVP and Chief Medical Officer |
18,397 | $0 | 288,442 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-06 5:54 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | SHERMAN JEFFREY W EVP and Chief Medical Officer |
102,264 | $0 | 288,442 (Direct) |
View |
| 2023-01-05 Tax Withholding |
2023-01-06 5:54 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | SHERMAN JEFFREY W EVP and Chief Medical Officer |
22,655 | $113.24 | 288,442 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 5:52 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | DesJardin Michael A. EVP, Technical Operations |
20,697 | $0 | 172,881 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-06 5:52 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | DesJardin Michael A. EVP, Technical Operations |
108,506 | $0 | 172,881 (Direct) |
View |
| 2023-01-05 Tax Withholding |
2023-01-06 5:52 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | DesJardin Michael A. EVP, Technical Operations |
26,901 | $113.24 | 172,881 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 5:48 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
91,987 | $0 | 1,067,750 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-06 5:48 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
444,990 | $0 | 1,067,750 (Direct) |
View |
| 2023-01-05 Tax Withholding |
2023-01-06 5:48 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
97,461 | $113.24 | 1,067,750 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 5:43 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Thompson Elizabeth H.Z. EVP, Research & Development |
20,697 | $0 | 20,697 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 5:41 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Cox Aaron EVP, Chief Financial Officer |
22,997 | $0 | 22,997 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 5:38 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP, Chief Strategy Officer |
22,997 | $0 | 22,997 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 5:35 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Clayton Sean M. EVP, General Counsel |
22,997 | $0 | 22,997 (Direct) |
View |
| 2023-01-01 Tax Withholding |
2023-01-04 4:27 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | SHERMAN JEFFREY W EVP and Chief Medical Officer |
9,717 | $113.8 | 220,091 (Direct) |
View |
| 2023-01-01 Exercise |
2023-01-04 4:27 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | SHERMAN JEFFREY W EVP and Chief Medical Officer |
21,772 | $0 | 220,091 (Direct) |
View |
| 2023-01-01 Tax Withholding |
2023-01-04 4:25 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | DesJardin Michael A. EVP, Technical Operations |
9,561 | $113.8 | 94,834 (Direct) |
View |
| 2023-01-01 Exercise |
2023-01-04 4:25 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | DesJardin Michael A. EVP, Technical Operations |
21,772 | $0 | 94,834 (Direct) |
View |
| 2022-12-30 Tax Withholding |
2023-01-04 4:21 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
53,094 | $113.8 | 770,594 (Indirect) |
View |
| 2022-12-30 Exercise |
2023-01-04 4:21 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
134,868 | $0 | 770,594 (Indirect) |
View |
| 2022-12-30 Tax Withholding |
2023-01-04 4:18 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Thompson Elizabeth H.Z. EVP, Research & Development |
9,449 | $113.8 | 35,515 (Direct) |
View |
| 2022-12-30 Exercise |
2023-01-04 4:18 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Thompson Elizabeth H.Z. EVP, Research & Development |
38,110 | $0 | 35,515 (Direct) |
View |
| 2022-12-30 Tax Withholding |
2023-01-04 4:14 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP, Chief Strategy Officer |
39,313 | $113.8 | 116,796 (Direct) |
View |
| 2022-12-30 Exercise |
2023-01-04 4:14 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP, Chief Strategy Officer |
177,466 | $0 | 116,796 (Direct) |
View |
| 2022-12-30 Tax Withholding |
2023-01-04 4:13 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Cox Aaron EVP, Chief Financial Officer |
28,758 | $113.8 | 66,263 (Direct) |
View |
| 2022-12-30 Exercise |
2023-01-04 4:13 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Cox Aaron EVP, Chief Financial Officer |
129,812 | $0 | 66,263 (Direct) |
View |
| 2022-12-30 Gift |
2023-01-04 4:09 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Himawan Jeff Director |
2,230 | $0 | 54,833 (Direct) |
View |
| 2022-12-27 Option Award |
2022-12-29 4:33 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
156,890 | $0 | 156,890 (Direct) |
View |
| 2022-12-27 Option Award |
2022-12-29 4:31 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | SHERMAN JEFFREY W EVP and Chief Medical Officer |
35,744 | $0 | 35,744 (Direct) |
View |
| 2022-12-27 Option Award |
2022-12-29 4:28 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP, Chief Strategy Officer |
43,588 | $0 | 43,588 (Direct) |
View |
| 2022-12-27 Option Award |
2022-12-29 4:26 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | DesJardin Michael A. EVP, Technical Operations |
37,767 | $0 | 120,113 (Direct) |
View |
| 2022-12-15 Gift |
2022-12-29 4:23 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Cox Aaron EVP, Chief Financial Officer |
4,774 | $0 | 31,665 (Direct) |
View |
| 2022-12-27 Option Award |
2022-12-29 4:23 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Cox Aaron EVP, Chief Financial Officer |
31,665 | $0 | 31,665 (Direct) |
View |
| 2022-12-13 Exercise |
2022-12-14 5:10 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP, Chief Strategy Officer |
23,251 | $29.52 | 34,047 (Direct) |
View |
| 2022-12-13 Exercise |
2022-12-14 5:10 pm |
N/A 2029-10-31 |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP, Chief Strategy Officer |
23,251 | $0 | 34,047 (Direct) |
View |
| 2022-05-27 Gift |
2022-12-13 4:12 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | SHERMAN JEFFREY W EVP and Chief Medical Officer |
8,531 | $0 | 153,535 (Direct) |
View |
Ownership |
2022-11-14 4:13 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | McIlvenny Patrick Chief Accounting Officer |
0 | $0 | 16,470 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-02 4:12 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP and Chief Business Officer |
12,421 | $0 | 40,965 (Direct) |
View |
| 2022-11-01 Tax Withholding |
2022-11-02 4:12 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Pasternak Andy EVP and Chief Business Officer |
5,503 | $63.18 | 40,965 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-03 7:04 pm |
N/A 2025-03-22 |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
25,000 | $0 | 1,427,630 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-03 7:04 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
25,000 | $22.14 | 1,427,630 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 6:07 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | LEONARDI JACOPO Pres., Global Commercial Ops |
44,466 | $0 | 44,466 (Direct) |
View |
| 2022-05-20 Exercise |
2022-05-20 6:15 pm |
N/A 2025-03-22 |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
25,000 | $0 | 1,477,076 (Direct) |
View |
| 2022-05-20 Exercise |
2022-05-20 6:15 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Walbert Timothy P Chairman, President and CEO |
25,000 | $22.14 | 1,477,076 (Direct) |
View |